This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Next revision Both sides next revision | ||
projects:workgroups:clinicalstudy [2021/06/29 15:38] mikehamidi |
projects:workgroups:clinicalstudy [2021/09/04 11:38] zhen |
||
---|---|---|---|
Line 5: | Line 5: | ||
**Objective**: To allow adequate representation of clinical trial data in OMOP. | **Objective**: To allow adequate representation of clinical trial data in OMOP. | ||
- | **First use case**: To convert clinical trial data in CDISC SDTM format to OMOP, with a view to allowing trial planning optimization. | + | **First use case**: To convert clinical trial data in [[https://www.cdisc.org/standards/foundational/sdtm|CDISC SDTM]] format to [[https://www.ohdsi.org/data-standardization/the-common-data-model/|OMOP]], with a view to allowing trial planning optimization. |
**Approach**: We advocate minimum changes to the OMOP CDM and Standardized Vocabularies because we want to ensure minimum impact on OHDSI tools like Atlas, whilst providing a value-add SDTM-to-OMOP conversion with minimum data loss. We have proposed conventions introducing new concepts and modifiers, but no new CDM tables; and providing guidance for ETL developers where appropriate. Our proposals are built on OMOP CDM v6 and the Oncology extension, with v5.3.1 backward compatibility. | **Approach**: We advocate minimum changes to the OMOP CDM and Standardized Vocabularies because we want to ensure minimum impact on OHDSI tools like Atlas, whilst providing a value-add SDTM-to-OMOP conversion with minimum data loss. We have proposed conventions introducing new concepts and modifiers, but no new CDM tables; and providing guidance for ETL developers where appropriate. Our proposals are built on OMOP CDM v6 and the Oncology extension, with v5.3.1 backward compatibility. | ||
Line 16: | Line 16: | ||
- | ==== Membership ==== | ||
- | |||
- | **WG co-leads**: | ||
- | [[https://www.linkedin.com/in/kamiar-mike-hamidi-0a908164/|Mike Hamidi]], Pfizer, US (Kamiar.Hamidi@pfizer.com) | ||
- | [[https://www.linkedin.com/in/zhen-lin/|Zhen Lin]], Robot Bacon, US (Zhen.Lin@ohdsi.org) | ||
- | |||
- | |||
- | **Current members**\\ | ||
- | {{:projects:workgroups:currentmembers_june_2021_v2_.png?600|}} | ||
- | ---- | ||
==== Important Links ==== | ==== Important Links ==== | ||
Line 40: | Line 30: | ||
**Schedule**: | **Schedule**: | ||
- | Biweekly calls on Fridays, 7AM PT/9AM CT/10AM ET/3PM UK time on Teams [[https://teams.microsoft.com/l/channel/19%3acc614694401a40b4b48668bd271cc9c0%40thread.tacv2/General?groupId=176311d3-ef0e-467c-bf6f-47c7f3aa82a0&tenantId=a30f0094-9120-4aab-ba4c-e5509023b2d5|here]] | + | Biweekly calls on Fridays, 7:30AM PT/9:30AM CT/10:30AM ET/3:30PM UK time on Teams [[https://teams.microsoft.com/l/channel/19%3acc614694401a40b4b48668bd271cc9c0%40thread.tacv2/General?groupId=176311d3-ef0e-467c-bf6f-47c7f3aa82a0&tenantId=a30f0094-9120-4aab-ba4c-e5509023b2d5|here]] |
//**Note on accessing Teams channel above:**\\ | //**Note on accessing Teams channel above:**\\ | ||
* If you use the Teams desktop app and have multiple accounts, ensure you are already in the OHDSI Teams account before clicking the link above\\ | * If you use the Teams desktop app and have multiple accounts, ensure you are already in the OHDSI Teams account before clicking the link above\\ | ||
* Alternatively, select the "web app" button in the link above for accessing meetings on your browser// | * Alternatively, select the "web app" button in the link above for accessing meetings on your browser// | ||
+ | |||
+ | ---- | ||
+ | |||
+ | ==== Membership ==== | ||
+ | |||
+ | **WG co-leads**: | ||
+ | [[https://www.linkedin.com/in/kamiar-mike-hamidi-0a908164/|Mike Hamidi]], Pfizer, US (Kamiar.Hamidi@pfizer.com) | ||
+ | [[https://www.linkedin.com/in/zhen-lin/|Zhen Lin]], Robot Bacon, US (Zhen.Lin@ohdsi.org) | ||
+ | |||
+ | |||
+ | **Active members**\\ | ||
+ | |||
+ | ^ Name ^ Organization ^ Location ^ ^ | ||
+ | | Rebecca Baker | CDISC | Austin, Texas, USA | | | ||
+ | | Mike Hamidi | Pfizer | USA | [[https://www.linkedin.com/in/kamiar-mike-hamidi-0a908164/|L]] | | ||
+ | | Michael Kallfelz | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
+ | | Zhen Lin | Robot Bacon | Houston, TX, USA | [[https://www.linkedin.com/in/zhen-lin/|L]], [[https://twitter.com/zhenLinPhDRN|T]] | | ||
+ | | Katy Sadowski | TrialSpark | New York, NY, USA | | | ||
+ | | Philip Solovyev | Odysseus Data Services Inc. | Cambridge, MA, USA | | | ||
+ | | Anthony Sunjaya | The George Institute for Global Health, UNSW Sydney | Sydney, NSW, Australia | | | ||
+ | | Tom Walpole | Trials.ai | San Diego, CA, USA | | ||
+ | | Ariana Winder | REDCap Cloud | Bellefonte, PA, USA | [[https://www.linkedin.com/in/amwinder/|L]] | | ||
+ | | Qi Yang | IQVIA | Plymouth Meeting, PA, USA | | | ||
+ | |||
+ | ---- | ||
+ | |||
+ | **Other members**\\ | ||
+ | |||
+ | ^ Name ^ Organization ^ Location | ||
+ | | Eldar Allakhverdiiev | Odysseus Data Services Inc. | Cambridge, MA, USA| ^ | ||
+ | | Sonia Araujo * | IQVIA | London, UK | | ||
+ | | Ted Bebi | Medidata | Boston, MA, USA | | ||
+ | | Lina Clover | SAS | Raleigh-Durham, NC, USA | | ||
+ | | Alexander Davydov | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
+ | | Shawn Dolley | Open Global Health | Arlington, Virginia, USA | | ||
+ | | Rhonda Facile | CDISC | Austin, Texas, USA | | ||
+ | | Vojtech Huser | National Library of Medicine, National Institutes of Health | Bethesda, MD, USA | | ||
+ | | Gregory Klebanov | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
+ | | Bess LeRoy | CDISC | Tucson, AZ, USA | | ||
+ | | James Liddil | M2Gen | Tampa, FL, USA | | ||
+ | | Asiyah Yu Lin | National Institute of Health | Bethesda, Maryland, USA | | ||
+ | | Maxim Moinat | The Hyve | Utrecht, The Netherlands | | ||
+ | | Alexandra Orlova | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
+ | | Joshua F. Ransom | BEKHealth Inc | Wayland, MA, USA | | ||
+ | | Chris Roeder | School of Medicine, University of Colorado | CO, USA | | ||
+ | | Cynthia Sung| Bill & Melinda Gates Medical Research Institute | Seattle, WA, USA| | ||
+ | | Emma Vos | The Hyve | Utrecht, The Netherlands| | ||
+ | | Andrew Williams | Tufts Institute for Clinical Research and Health Policy Studies | Boston, MA, USA | | ||
+ | |||
+ | * Past leads | ||
---- | ---- |